Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

Delayed Data
As of Oct 26
 -0.21 / -0.95%
Today’s Change
Today|||52-Week Range
Bill Miller: Valeant Can Double in 3 Years
Oct 26 / GuruFocus News - Paid Partner Content
Mr. Market Coming Off Session Lows
Oct 24 / TheStreet.com - Paid Partner Content
Is This MannKind's Last Remaining Option?
Oct 25 / MotleyFool.com - Paid Partner Content
Headline Risk Is Still Poison For These Stocks
Oct 20 / GuruFocus News - Paid Partner Content
A Month Later, the For Sale Sign Still Sits in iNova's Front Yard, Much to Valeant's ...
Oct 25 / MotleyFool.com - Paid Partner Content
Biotech Bargain Bin Bursts With Bounty
Oct 20 / TheStreet.com - Paid Partner Content
Valeant (VRX) Stock Down, JPMorgan: Avoid Before Q3 Results
Oct 24 / TheStreet.com - Paid Partner Content
3 Things Valeant Pharmaceuticals Needs to Do to Win Over Wall Street
Oct 17 / MotleyFool.com - Paid Partner Content
Valeant Pharmaceuticals (VRX) Stock Could Double in Three Years, LMM CIO Bill Miller ...
Oct 24 / TheStreet.com - Paid Partner Content
Why Biotech Investors Are Terrified of the Upcoming Elections
Oct 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close22.05
Today’s open21.92
Day’s range21.67 - 22.19
Average volume (3 months)22,345,092
Market cap$7.5B
Dividend yield--
Data as of 4:00pm ET, 10/26/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-36.21%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+26.42%
P/E ratioNM


% change
SGENSeattle Genetics Inc-0.05-0.10%
JAZZJazz Pharmaceuticals...-1.40-1.18%
RDYDr.Reddy's Laborator...+0.20+0.41%
ALKSAlkermes Plc-1.22-2.24%
Data as of 4:02pm ET, 10/26/2016


Next reporting dateNovember 8, 2016
EPS forecast (this quarter)$1.76
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%


Health Technology
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec


Search for Jobs